Participantes
DIRECCIÓN
Michael Duchen
University College London, UK
Antonio G. García
Universidad Autónoma de Madrid, Spain
SECRETARÍA
Luis Gandía Juan
Universidad Autónoma de Madrid, Spain
PARTICIPANTES
Natividad Alcorta Sevillano
Instituto Investigación Sanitaria Biocruces Bizkaia
Katherine Benson
Royal College of Surgeons in Ireland, Ireland
María A. Blasco
Centro Nacional de Investigaciones Oncológicas, Madrid, Spain
Elena Caldero Escudero
Universidad de Valladolid
Anitta Rose Chacko
University College London
Tobias Engel
Royal College of Surgeons in Ireland, Dublin, Ireland
Olivia Gillham
University College London
Anna Lisa Giuliani
University of Ferrara, Ferrara, Italy
Miguel Ángel Huerta Martínez
Universidad de Granada
Enrique Jiménez Madrona
Universidad de Sevilla
Michael Kossifos
University College London
Swati Kumar
University College London
Ashley Lam
University College London
José Alberto López Domínguez
Institute for Research in Biomedicine, Barcelona, Spain
Andrea López Martínez
Instituto Investigación Sanitaria Biocruces Bizkaia
Victoria Maneu Flores
Universidad de Alicante
Cristina Molina López
Instituto Murciano de Investigación Biosanitaria
Carlos Núñez de la Calle
Universidad Complutense de Madrid
Adrián Núñez Sancho
Universidad Complutense de Madrid
Marina Paredes Nieto
Instituto Teófilo Hernando/UAM
Aitor Picos Martínez
Universidad de Santiago de Compostela
Silvia Romero Sanz
Universidad de Valladolid
Miriam Santos Caballero
Universidad de Granada
Francesco Saverio Tedesco
University College London, UK
Myriam Torres Rico
Instituto Teófilo Hernando/UAM
Gabriel Valdebenito
University College London
Natalie Yivgi-Ohana
MINOVIA, Israel
Rafael Yuste
Columbia University, New York, USA
Programa
Lunes, 20 Junio 2022
10:00
School inauguration by directors and UIMP academic authority
10:30
Senolytic therapies in cancer and other diseases
José Alberto López Domínguez
12:00
Telomers and telomerase in cancer and ageing
María A. Blasco
15:00
Young Researcher Presentations (YRP-1)
Coordinator
Luis Gandía Juan
Developing therapies for retinal protection
Victoria Maneu Flores
Laparotomy in the mouse: a traslacional model of postoperative pain
Miriam Santos Caballero
Multimodal analgesia: sigma-1 receptor blockade to increase the therapeutic potential of NSAIDs
Miguel Ángel Huerta Martínez
Effect of kinurenin monoxygenase inhibition by Ro 61-8048 on the developtment of addictive behaviors induced by fentanyl
Carlos Núñez de la Calle
Antiproliferative effect of boldine on Neural Progenitor Cells of the rodent Subventricular Zone and glioblastoma multiforme cells
Enrique Jiménez Madrona
Martes, 21 Junio 2022
10:00
Mitochondrial pathways as therapeutic targets for human disease
Michael Duchen
12:00
Mitochondrial cell therapy
Natalie Yivgi-Ohana
15:00
Young Researcher Presentations (YRP-2)
Coordinator
Luis Gandía Juan
Drug screeningon OI human experimental models: increasing the osteoanabolic potential of MSCs
Natividad Alcorta Sevillano
Characterization of myotonic dystrophy type I cell models for drug screening
Andrea López Martínez
Submaximal inhibution of sca-1 (SERCA) enhances lifespan and healthspan in a chemical model of Parkinson's disease in C. elegans
Silvia Romero Sanz
Modulation of calcium homeostasis improves genertic and sporadic Alzheimer's disease in Caenorhabditis elegans models
Elena Caldero Escudero
Evaluation of sodium nitroprusside effects on bEnd.3 cells after oxygen and glucose deprivation and reoxygenation; a disappointing story
Aitor Picos Martínez
Miércoles, 22 Junio 2022
10:00
Reprogramming human skeletal muscle regeneration: new strategies for neuromuscular modelling and therapy
Francesco Saverio Tedesco
12:00
Neurodegeneration, neuroprotection and drug repositioning
Antonio G. García
15:00
Young Researcher Presentations (YRP-3)
Coordinator
Luis Gandía Juan
Structural and interactions studies of chondroitin sulfate mimetics with growth factors
Myriam Torres Rico
In silico Drug Repositioning for Neurodegenerative Diseases
Marina Paredes Nieto
Using iPSC-derived neural cells to model Down syndrome-associated neurodegeneration and identify new therapeutic targets
Olivia Gillham
Exploring novel treatment strategies for primary mitochondrial disease
Anitta Rose Chacko
Exploring novel treatment strategies to rescue mitochondrial function in cell models of the m.3243A G mutation using hiPSC-derived myotubes
Gabriel Valdebenito
Jueves, 23 Junio 2022
10:00
Targeting mRNA polyadenylation as a novel therapeutic approach to treat drug refractory epilepsy
Tobias Engel
12:00
Epilepsy as a model for precision therapeutics
Katherine Benson
15:00
Young Researcher Presentations (YRP-4)
Coordinator
Luis Gandía Juan
Effect of nanoplastics on inflammasome activation
Adrián Núñez Sancho
NLRP3 with mutations related to Cryopyrin associated-periodic syndromes results in a constitutively active inflammasome
Cristina Molina López
Using restriction endonucleases for targeting mtDNA for cancer gene therapy
Swati Kumar
Bioenergetic characterisation of c-Myc driven tumours
Michael Kossifos
Bioenergetic characterisation of c-Myc driven tumours
Ashley Lam
Viernes, 24 Junio 2022
10:00
Targeting purinergic check-points in inflammation and cancer
Anna Lisa Giuliani
12:00
Closing lecture
The novel neurotechnologies: implication for science and medicine
Rafael Yuste
13:00
Closing ceremony
Michael Duchen
Antonio G. García